BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 4th Quarter - Termination

REATA PHARMACEUTICALS

via UPSTREAM CONSULTING

4th Quarter (Oct 1 - Dec 31) · 2012Posted Jan 22, 2013Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: REATA PHARMACEUTICALS
Description: biopharmaceutical company
Location: Texas · United States of America

Registrant

Firm: UPSTREAM CONSULTING
Description: Government Relations
Location: Catharpin, Virginia, United States of America

Lobbying activities

1 issue

Health Issues
health issues
LobbyistsYARDLY POLLAS-KIMBLE · JOHN M. HADDOW
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

REATA PHARMACEUTICALS — Lobbying — Receipts Report